Leena
LEENA- norethindrone and ethinyl estradiol
Mayne Pharma Inc.
PHYSICIAN LABELING
Rx only
Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases.
ORAL CONTRACEPTIVE AGENTS
DESCRIPTION
Leena® provides a continuous oral contraceptive regimen of 7 light blue tablets, 9 light yellow-green tablets, 5 more light blue tablets, and then 7 orange tablets. Each light blue tablet contains norethindrone 0.5 mg and ethinyl estradiol 0.035 mg, each light yellow-green tablet contains norethindrone 1 mg and ethinyl estradiol 0.035 mg, and each orange tablet contains inert ingredients.
Norethindrone is a potent progestational agent with the chemical name 17-Hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one. Ethinyl estradiol is an estrogen with the chemical name 19-Nor-17α-pregna-1,3,5 (10)-trien-20-yne-3,17-diol. Their structural formulae follow.
The light yellow-green Leena tablets contain the following inactive ingredients: D&C Green No. 5, D&C Yellow No. 10, lactose, magnesium stearate, povidone, and starch.
The light blue Leena tablets contain the following inactive ingredients: FD&C Blue No. 1, lactose, magnesium stearate, povidone, and starch.
The inactive orange tablets contain the following inactive ingredients: FD&C Yellow No. 6, lactose, microcrystalline cellulose, and magnesium stearate.
CLINICAL PHARMACOLOGY
Combination oral contraceptives act by suppression of gonadotrophins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cervical mucus (which increase the difficulty of sperm entry into the uterus) and the endometrium (which may reduce the likelihood of implantation).
Leena Indications and Usage
Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.
Oral contraceptive products such as Norinyl, which contain 50 mcg of estrogen, should not be used unless medically indicated.
Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception.1 The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates.
% of Women Experiencing an Unintended Pregnancy within the First Year of Use | % of Women Continuing Use at One Year * | |||
---|---|---|---|---|
Method | Typical use † | Perfect use ‡ | ||
(1) | (2) | (3) | (4) | |
Emergency Contraceptive Pills: Treatment initiated within 72 hours after unprotected intercourse reduces the risk of pregnancy by at least 75%.§ | ||||
Lactational Amenorrhea Method: LAM is a highly effective, temporary method of contraception.¶ | ||||
Source: Trussell J. Contraceptive Efficacy Table from Hatcher R.A., Trussell J, Stewart F, Cates W, Stewart GK, Kowal D, Guest F, in Contraceptive Technology: Seventeenth Revised Edition. New York, NY: Irvington Publishers, 1998. | ||||
| ||||
Chance # | 85 | 85 | ||
Spermicides Þ | 26 | 6 | 40 | |
Periodic abstinence | 25 | 63 | ||
Calendar | 9 | |||
Ovulation method | 3 | |||
Sympto-thermal ß | 2 | |||
Post-ovulation | 1 | |||
Withdrawal | 19 | 4 | ||
Cap à | ||||
Parous women | 40 | 26 | 42 | |
Nulliparous women | 20 | 9 | 56 | |
Sponge | ||||
Parous women | 40 | 20 | 42 | |
Nulliparous women | 20 | 9 | 56 | |
Diaphragm à | 20 | 6 | 56 | |
Condom è | ||||
Female (Reality) | 21 | 5 | 56 | |
Male | 14 | 3 | 61 | |
Pill | 5 | 71 | ||
Progestin only | 0.5 | |||
Combined | 0.1 | |||
IUD | ||||
Progesterone T | 2.0 | 1.5 | 81 | |
Copper T 380A | 0.8 | 0.6 | 78 | |
LNg 20 | 0.1 | 0.1 | 81 | |
Depo-Provera | 0.3 | 0.3 | 70 | |
Norplant and Norplant-2 | 0.05 | 0.05 | 88 | |
Female sterilization | 0.5 | 0.5 | 100 | |
Male sterilization | 0.15 | 0.10 | 100 |
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.